Cancer

Initial Results of the Study of Tamoxifen and Raloxifene or STAR, released today revealed the osteoporosis drug raloxifene has been proved to be as effective as tamoxifen in preventing invasive breast cancer. Read More

Researchers at the Vanderbilt-Ingram Cancer Center are studying whether exercise can help curb memory and cognitive problems experienced by many cancer survivors following chemotherapy. Read More

Ginseng, one of the most widely used herbs in traditional Chinese medicine, may improve survival and quality of life after a diagnosis of breast cancer, according to a recent study by Vanderbilt-Ingram Cancer Center researchers. The large epidemiological study, led by Xiao-Ou Shu, M.D., Ph.D., was published online recently in the American Journal of Epidemiology. Read More

A team of researchers at Vanderbilt-Ingram Cancer Center has been awarded $1.5 million from the Susan G. Komen Breast Cancer Foundation. Read More

Can the high doses of chemotherapy and radiation that young cancer patients receive cause inherited health problems for their children? Read More

Thanks to Vanderbilt-Ingram Cancer Center's new Clinical Trials Mentor Program, patients considering enrolling in a clinical trial can now ask questions and get first-hand accounts from patient advocates who have already gone through the process. Read More

The Vanderbilt-Ingram Cancer Center has been chosen by the National Cancer Institute to join an elite group of researchers asked to test the most cutting-edge cancer treatments in Phase II clinical trials in both solid tumor and hematologic malignancies. Read More

Researchers at the Vanderbilt-Ingram Cancer Center have uncovered a clue to explain the invasive nature of an aggressive kind of brain tumor called glioblastoma multiforme, or gliomas, and their findings are published in this week's online edition of the journal Oncogene. Read More

The Vanderbilt-Ingram Cancer Center is leading a multi-institutional effort supported by the National Cancer Institute (NCI) to identify "molecular signatures" of lung cancer. Read More

The U.S. Food and Drug Administration has approved the first new therapy in almost a decade for pancreas cancer, the fourth leading cause of cancer death in the United States. Read More

When a woman is diagnosed with breast cancer, multiple clinic visits may begin to mount, along with questions that the patient wants answered sooner rather than later. Read More

Cancer patients displaced by Hurricane Katrina and its aftermath who are in Middle Tennessee and Southern Kentucky and in need of continued treatment can contact the Vanderbilt-Ingram Cancer Center for assistance. Read More

The Vanderbilt-Ingram Cancer Center will launch a new research institute, jump-started with a $10 million gift from West Tennessee businessman Jim Ayers, to develop techniques to detect cancers at their earliest, most curable stages, Vanderbilt officials announced today. Read More

Women and teen-age girls have yet one more reason to become more physically active ñ reduction of their risk of developing the most common gynecologic malignancy, endometrial cancer, researchers at Vanderbilt University Medical Center and its Vanderbilt-Ingram Cancer Center report. Read More

Fashion seems to permeate popular culture these days-be it the trend-setting frocks worn by the characters on the popular HBO series Sex and the City, or the many magazine pages devoted to the red carpet fashion of the recent Academy Awards. To an extent, the Vanderbilt campus is no different. Read More

Researchers have moved a step closer to finding a "molecular fingerprint" of an individual's cancer. Read More

Researchers are working to understand the process of how cancer cells develop the ability to migrate from their original location, settle and begin growing in another distant organ. Read More

Laurel Brown, PhD, assistant professor of psychiatry, is the principal investigator of a pilot study currently underway in The Vanderbilt Ingram Cancer Center, in conjunction with the Departments of Psychiatry and Psychology to uncover the cause of cognitive deficits many breast cancer patients experience after being treated with chemotherapy, often referred to as "chemo brain" or "chemo fog." Read More

A team of Vanderbilt-Ingram Cancer Center physician-scientists gathered with their colleagues here earlier this week to hear, discuss and present some of the latest advances in care for patients with cancer. Read More

The Vanderbilt-Ingram Cancer Center is now offering a technique that uses a light-activated drug to help restore the ability to swallow in patients whose esophagus is blocked by cancer. Read More